Open AccessStopping Imatinib in CML: Safe in the Long Term for Deep Molecular Responders As the Immune System Steps Up
Author(s) -
Andrew W. Roberts
Publication year - 2017
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v14.3.7261
Subject(s) - imatinib , term (time) , immune system , medicine , immunology , myeloid leukemia , physics , quantum mechanics